首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world practice settings

【24h】

Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world practice settings

机译：激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者的生活质量在现实世界实践环境中对帕尔博克尼治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共4页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world practice settings [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者的生活质量在现实世界实践环境中对帕尔博克尼治疗
2. Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib plus letrozole: results from MONALEESA-2 [J] . Verma Sunil, OShaughnessy Joyce, Burris Howard A., Breast cancer research and treatment. . 2018,第3期

机译：与激素受体阳性，人体表皮生长因子受体2阴性晚期乳腺癌的卫生症患者患者的卫生症患者的妇女生活质量阳性，用核发生杆菌加仑唑唑：Monaleesa-2的结果
3. Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib plus letrozole: results from MONALEESA-2 [J] . Verma Sunil, OShaughnessy Joyce, Burris Howard A., Breast cancer research and treatment. . 2018,第3期

机译：与激素受体阳性，人体表皮生长因子受体2阴性晚期乳腺癌治疗的健康相关性生活质量，用核心杆菌加仑唑唑治疗：Monaleesa-2的结果
4. Identification of Human Epidermal Growth Factor Receptor 2 Antagonist In Silico for Breast Cancer Therapy, Derived from Indonesian Phytochemicals [C] . Tuti Ratnasari, Dono indarto, Raden Ajeng Sri Wulandari, International Conference on Biomedical Engineering . 2018

机译：人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
5. Treatment Interruption and Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients [D] . Mao, Daqin . 2020

机译：激素受体阳性乳腺癌患者中的治疗中断与激素治疗中的中断和停止
6. Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China [O] . Chang Liu, Ting Li, Zhonghua Tao, 2020

机译：用Palbociclib加内分泌治疗和随后治疗治疗130例激素受体阳性和人表皮生长因子受体2阴性转移性乳腺癌患者的临床结果和疗法：中国的真实单中心回顾性研究
7. Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2 [O] . Sunil Verma, Joyce O’Shaughnessy, Howard A. Burris, 2018

机译：与激素受体阳性的后代妇女的健康状生活质量，人体表皮生长因子受体2阴性晚期乳腺癌用核核苷酸处理，MonaleEsa-2结果

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号